Synchrony Medical and Sheba Medical Center Initiate 1st Clinical Trial Using a Personalized Chest Physiotherapy System for Patients Living with Chronic Lung Diseases

Prevail Drug Coated Balloon Catheter Launches in Europe

Prevail Drug coated balloon catheter is used during percutaneous coronary intervention procedures to treat narrowed or blocked coronary arteries in patients with coronary artery disease.

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

Dr. Moshe Ashkenazi (Left), Mr. Gil Sokol, Prof. Ori Efrati, and Ms. Anat Shani

April 6, 2021

Synchrony Medical* is a medical device company developing a personalized chest physiotherapy system designed to provide efficient airway clearance. They recently initiated a clinical trial at The National Cystic Fibrosis Center of Israel, at Sheba Medical Center**.

Synchrony Medical notes the trial aims to test the functionality of the system and compare its airway clearance effectiveness to the standard of care solutions currently used in Cystic Fibrosis and Bronchiectasis patients.

“Effective airway clearance on a daily basis at home is the key to keeping chronic lung patients stable and breaking the vicious cycle of clinical deteriorations,” said Dr. Moshe Ashkenazi, Pediatric Pulmonologist, Deputy Director, Safra Children’s Hospital, Sheba Medical Center, and Synchrony Medical’s Co-founder.

Synchrony Medical has developed a novel airway clearance system based on a unique chest physiotherapy method developed at the National Cystic Fibrosis Center of Israel, Sheba Medical Center. The system includes real-time sensing for an adaptive treatment to achieve effective airway clearance.

“Our system will enable patients to receive state-of-the-art chest physiotherapy independently, in the comfort of their own home,” explained Anat Shani, CEO of Synchrony Medical. “By making this effective therapy accessible, Synchrony Medical will bring to patient’s years of experience from Sheba’s respiratory experts and may help minimize pulmonary exacerbations and costly hospitalization associated with chronic lung diseases. This trial brings us one step closer to our goal: improving the lives of millions of chronic lung disease patients who deserve better airway clearance solutions.”

Synchrony Medical is a portfolio company of MEDX Xelerator, a medical device incubator formed as an initiative of MEDX Ventures Group together with Boston Scientific, Intellectual Ventures and Sheba Medical Center.

*Synchrony Medical, a portfolio company of MEDX Xelerator, is a clinical stage medical device company innovating airway clearance for patients living with chronic lung diseases. Synchrony’s system will enable patients to receive high quality chest physiotherapy independently at the comfort of their home.

The system synchronizes a unique chest compression sequence and the delivery of positive airway pressure with the patient’s breathing cycle, according to a personalized treatment algorithm. It is based on a unique airway clearance method developed at the National CF Center of Israel, at the Sheba Medical Center.

**The largest and most comprehensive medical center in the Middle East, Sheba Medical Center, Tel Hashomer is generating global impact through its medical care, research and healthcare transformation. Sheba’s City of Health boasts an acute-care hospital, rehabilitation hospital, research and innovation hubs, medical simulation center and center for disaster response on one comprehensive campus in the center of Israel.

A university teaching hospital affiliated with the Sackler School of Medicine at Tel-Aviv University, Sheba is shaping the future of healthcare, educating the next generation of care providers. Sheba serves as a true hospital without borders, welcoming patients and healthcare professionals from all over the world and consistently providing the highest-level medical care to all in need. Sheba has been ranked a top-ten hospital in the world by Newsweek three years in a row (2019, 2020, 2021).



Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.